MedPath

Financial Incentives and Recruitment to the APT Webstudy

Not Applicable
Completed
Conditions
Alzheimer Disease
Dementia
Prodromal Alzheimer's Disease
Preclinical Alzheimer's Disease
Registration Number
NCT06033066
Lead Sponsor
University of Southern California
Brief Summary

This single-blind, three-arm, randomized, controlled trial will assess the impact of messages and financial incentives on the enrollment of demographically diverse individuals to the Alzheimer Prevention Trials (APT) Webstudy. The APT Webstudy is a novel, online registry that employs quarterly cognitive testing using validated platforms. The APT Webstudy implements fully remote assessments, coordinated by the Alzheimer's Therapeutic Research Institute (ATRI) under USC IRB #HS-17-00746. The purpose of the current study is to test whether we can increase enrollment of diverse individuals into the registry. To do this, we will work with Contra Costa Regional Medical Center (CCRMC), the county public hospital and its affiliated health centers in Contra Costa County, California, to test whether sending messages with and without financial incentives to patients who receive primary care with the health system can increase enrollment to the APT Webstudy. The investigators hypothesize that 1) a certain small financial incentive and an award opportunity based incentive (or a drawing with a prize) will increase enrollment rates of CCHS members into the APT Webstudy relative to the control group. The investigators further hypothesize that the award opportunity incentive will increase the enrollment rate of CCRMC patients into the APT Webstudy more than a certain financial incentive with the same expected value.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
44844
Inclusion Criteria

To be eligible to participate in this study, an individual must meet all of the following criteria:

  • Patients empaneled at Contra Costa Regional Medical Center (CCRMC), the county public hospital and its affiliated health centers.
  • Age 50 or older
  • Literate in either English or Spanish
Exclusion Criteria
  • Below age 50
  • Documentation of prior dementia diagnosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Enrollment status into the APT Webstudy2-weeks

APT Webstudy enrollment rate based on completion of at least one of the two APT Webstudy cognitive assessments (Cognitive Function Instrument \[CFI\] and/or Cogstate Brief Battery).

Secondary Outcome Measures
NameTimeMethod
Cost per enrolleeannual

Cost to acquire an enrollment

Completion of cognitive assessments within the APT Webstudy2-weeks

Completion of both APT Webstudy cognitive assessments (Cognitive Function Instrument \[CFI\] and/or Cogstate Brief Battery).

Trial Locations

Locations (1)

Contra Costa Health Plan

🇺🇸

Martinez, California, United States

Contra Costa Health Plan
🇺🇸Martinez, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.